Macular Degeneration Treatment Market Size And Share

Report Code : TIPRE00004433
Category : Life Sciences

No. of Pages : 150

Buy Now

Marktgröße und Marktanteilsanalyse für die Behandlung von Makuladegeneration bis 2025 – 2031

Buy Now

Macular Degeneration Treatment Market Report Analysis

Macular Degeneration Treatment Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

GlaxoSmithKline plc
Novartis AG
Bayer AG
Neurotech Pharmaceuticals, Inc
Ophthotech Corporation
F. Hoffmann-La Roche Ltd
StemCells Inc
Pfizer, Inc
Sanofi

Regional Overview

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika
Naher Osten und Afrika

Market Segmentation

By Krankheitsindikation

Behandlung der altersbedingten trockenen Makuladegeneration
Behandlung der altersbedingten feuchten Makuladegeneration
Sonstiges

By Arzneimittelklasse

Anti-vaskulärer endothelialer Wachstumsfaktor
Sonstige

By Endbenutzer

Ambulante chirurgische Zentren
Augenkliniken
Krankenhäuser

By Geographie

Nordamerika
Europa
Asien-Pazifik
Süd- und Mittelamerika